Pharmaceuticals News & Press Release Distribution

Pharmaceuticals

APAC
Global

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...

2020-01-07 22:00 1071

genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models

genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system LYON, France, Jan. 7, 2020 /PRNewswire/ -- genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic ...

2020-01-07 09:00 3101

InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab

SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of Merck & C...

2020-01-07 08:25 3612

Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review

SALT LAKE CITY and TOKYO, Jan. 7, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that IDCT has p...

2020-01-07 08:00 1483

Inovio Provides Update on Clinical Program Plans for 2020

Inovio to present 2020 program plans at Biotech Showcase 2020 Conference PLYMOUTH MEETING, Pennsylvania, Jan. 6, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical progr...

2020-01-06 21:00 3057

BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media - At the planned interim analysis, Phase III JAVELIN Bladder 100 study met the primary endpoint of prolonging overall survival (OS) as a first-line maintenance treatment versus standard of care - BAVENCIO is the first immunotherapy to signifi...

2020-01-06 20:00 4804

Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its appointment of Mr.John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commercialization, and will report directly to Dr.Jay Mei, ...

2020-01-06 20:00 3726

Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability

- Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSure™ - Opportunity to combine Expedeon and Abcam's technologies to create new products to support research and diagnostic development CAMBRIDGE, England, Jan. 6, 2020 /PRNewswire/ -- Abcam plc, a glo...

2020-01-06 15:00 1015

GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR

GUANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- The beginning of 2020 witnessed key projects promoting the cooperation betweenGuangdong and Macao. On January 3 , Guangzhou Pharmaceutical Group (Macau) International Development Co., Ltd. (hereunder referred to as "the company") was established inMac...

2020-01-06 14:39 1373

GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR

Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment

GAITHERSBURG, Md. and AMBLER, Pa., Jan. 6, 2020 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, and Tavotek Biotherapeutics, a biotech c...

2020-01-06 09:00 3279

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

TAIZHOU, China, Jan. 3, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"),(NASDAQ: SXTC) announced today that on December 27, 2019 the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifyi...

2020-01-03 23:30 6842

1 ... 314 315 316 317318